01 1Viatris
01 1CELECOXIB USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-03-25
Pay. Date : 2014-03-13
DMF Number : 17697
Submission : 2004-09-22
Status : Active
Type : II
20
Matrix Pharmacorp Private Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CELECOXIB USP, with a corresponding US DMF Number 17697.
Remarkably, this DMF maintains an Active status since its submission on September 22, 2004, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 25, 2014, and payment made on March 13, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
